Suchergebnisse - "Antibody-drug conjugates"

PubPharm (3.352)

1

Reforming solid tumor treatment : the emerging potential of smaller format antibody-drug conjugate

enthalten in: Antibody therapeutics | 2024

von Ma, X. | Wang, M. | Ying, T. | +1

2

Emerging immunotherapies in the Hodgkin Lymphoma Armamentarium

enthalten in: Expert opinion on emerging drugs | 2024

von Spinner, M. | Advani, R.

3

"Negative" Impact : The Role of Payload Charge in the Physicochemical Stability of Auristatin Antibody-Drug Conjugates

enthalten in: Journal of pharmaceutical sciences | 2024

von Johann, F. | Wöll, S. | Gieseler, H.

4

Evaluating the Potential of Cyclodextrins in Reducing Aggregation of Antibody-Drug Conjugates with Different Payloads

enthalten in: Journal of pharmaceutical sciences | 2024

von Johann, F. | Wöll, S. | Gieseler, H.

5

Incidence of antibody-drug conjugate-related fatigue in patients with breast cancer : A systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2024

von Zhang, H. | Shen, G. | Yang, P. | +9

6

Antibody drug conjugates : Design implications for clinicians

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Pang, S. | Duong, A. | Siu, C. | +1

7

Top advances of the year : Cervical cancer

enthalten in: Cancer | 2024

von Duska, L. | Podwika, S. | Randall, L.

8

Antibody Drug Conjugates in Urological Cancers : A Review of the Current Landscape

enthalten in: Current oncology reports | 2024

von Ghose, A. | Lapitan, P. | Apte, V. | +14

9

Side effects of drug-antibody conjugates enfortumab-vedotin and sacituzumab-govitecan in targeted therapy in cancer

enthalten in: Cancer epidemiology | 2024

von Reike, M. | Bahlburg, H. | Brehmer, M. | +5

10

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors : updated safety and efficacy outcomes

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Loriot, Y. | Petrylak, D. | Rezazadeh Kalebasty, A. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[336]